Based on the structure of 4',8-dihydroxyisoflavon-7-yl α-D-arabinofuranoside (namely A-76202, 1), a Rhodococcus metabolite showing potent inhibitory activities against the α-glucosidases of rat liver microsome (IC 50 = 0.46 ng/mL), 26 analogs each with minor variations at the sugar moiety, the isoflavone A, and B rings, respectively, are readily synthesized. Notably, a new and efficient method is developed for the divergent synthesis of the B-ring congeners of the isoflavone glycosides using Suzuki-Miyaura coupling as the final step. Modifications at the sugar moiety and the isoflavone A ring significantly diminish the activity, while variations on the B ring are largely tolerated for retaining the potent α-glucosidase inhibitory activity.
Introduction
The generation of glycoproteins involves the cotranslational transference of 1 the tetradeca-oligosaccharide Glc 3 Man 9 GlcNAc 2 from the dolichyl diphosphate to the N-asparagine of the nascent protein, by the action of the oligosaccharyl-transferase in the lumen of the reticulum endoplasmatic membrane. [1] Then the processing enzymes, α-glucosidase I and II, cleave the Glc(1→2)Glc and Glc(1→3)Glc linkages in this N-linked oligosaccharide respectively, to liberate the three terminal glucose residues. [2] This immature glycoprotein is further processed by the concomitant action of glycosidases and transferases to give specific glycoconjugates, which play fundamental roles in the biological processes, such as the immune response, intercellular recognition, cellular differentiation, the stability and solubility of proteins, and in pathological processes, such as inflammation and cancer. [3] Tremendous efforts have been given to the development of glucosidase inhibitors which are of potentially usefulness for the treatment of diabetes, [4] obesity, [5] glycosphingolipid lysosomal storage disease, [6] HIV infections, [7] and tumors. [8] The potent inhibitors with IC 50 at nM level are largely structural mimics of the transition state of the hydrolyses of the glucosidic linkage. [9] In this regard, 4',8-dihydroxyisoflavon-7-yl α-D-arabinofuranoside (1) is an exception which shows potent inhibitory activity (against the α-glucosidases of rat liver mcrosome) with an IC 50 of 0.46 ng/mL. [10] This isoflavone glycoside, named A-76202, was isolated by Takatsuki et al. in 1996 from Rhodococcus sp. SANK 61694. Shiozaki et al. have synthesized this compound along with several hexopyranoside analogs (2) , and evaluated their α-glucosidase inhibitory activities. [11] However, these hexose analogs were found inactive. We have developed a general approach to the synthesis of flavone 7-O-glycosides, such as A-76202 (1) . [12] Here we report the synthesis of a series of the analogs of 1, each with minor variations at the sugar moiety, the isoflavone A, and B rings, respectively, and the evaluation of their α-glucosidase inhibitory activities. 
Results and Discussion

Synthesis
Adopting modification of our previous method for the synthesis of flavone 7-O-glycosides, [12] the desired 4',8-dihydroxyisoflavon-7-yl pentosides (9a-d) and the natural product 1 as well were readily prepared via glycosylation of the ready available 4',8-di-O-hexanoyl isoflavone derivative 8 [12] with the corresponding peracetyl pentosyl trichloroacetimidates 3-7 [13] [14] [15] [16] [17] under the promotion of BF 3 ·OEt 2 and subsequent removal of the acyl groups with K 2 CO 3 in a mixed solvent of MeOH/THF/H 2 O (Scheme 1). The yields (over two steps) are only moderate (26%-76%); partial migration of the 8-O-hexanoyl group onto the neighboring 7-OH under the glycosylation conditions was observed. Thus, acylation of pyrogallol with glacial acetic acid under the action of BF 3 ·OEt 2 at 90∼100 o C provided ketone 10, which was treated with triethyl orthoformate in the presence of 70% HClO 4 to afford chromone 11 (Scheme 2).
Selective protection of the 5-OH in diol 11 was achieved via 5,7-di-O-hexanoate formation and subsequent removal of the 7-O-acyl group, [12] which is para to the electron-withdrawing pyrone carbonyl function, with PhSH and imidazole in N-methyl pyrolidinone (NMP) to give 12 (70% for two steps). Glycosylation of phenol 12 with 2,3,5-tri-O-acetyl-D-arabinofuranosyl trichloroacetimidate (3) under the promotion of BF 3 ·OEt 2 led to the α-glycoside 13 in 62% yield. Bromination of compound 13 was achieved with PhI(OAc) 2 and TMSBr at room temperature with pyridine as a base, [19] Although Suzuki-Miyaura reaction has been widely used as one of the most efficient methods for C-C bond formation, [18] as a ligand, as introduced by Buchwald et al, [21] in the presence of Pd(OAc) 2 and K 2 CO 3 , coupling of bromide 15 with a variety of the aryl boronic acids provided the corresponding isoflavone glycosides 22a-n in moderate yields ( Table 1) . Reduction of the bromide and degradation of the chromone B ring are the major side reactions. Under similar conditions, the couplings with chromon-3-bromide 21 gave lower yields of the desired product (Table 2) , because chromone 21 was found more vulnerable to basic degradation than its region-isomer 15. An alternative procedure for this coupling was in the absence of ligand and with NaOAc as a base, but the coupling yields were even lower. 
Inhibitory activities against α-glucosidases
The synthetic natural product 1 exhibited potent inhibitory activity against the α-glucosidases of rat liver microsome, with an IC 50 = 18 nM, that is comparable to the literature value of 14 nM. [11b] However, none of the stereoisomers (9a-d) showed remarkable activities at concentrations up to 10 μM. Gratifyingly, all the B ring analogs of 1 (22a-n) exhibited activities at 10 nM concentration (Table 3 ). The 4-OH in the B ring of 1 could be replaced by -OMe, -H, -F, -Me, and -CF 3 without considerably affecting the activity. Their regio-isomers, i.e., the 3-OH, 2-OMe, 3-OMe, 2-Me, and 3-Me derivatives, were similarly potent. Especially, the 3-OMe and 4-NMe 2 derivatives (22d and 22l) were about 3-fold more potent that the 4'-OH natural product (1). However, the 5-OH (on the A ring) derivatives, which are regio-isomers of the above 8-OH isoflavone glycosides (22a-n) were 1000 times less potent inhibitiors. Worth of noting is that all these compounds, including the natural flavone glycoside 1, were found inert toward the α-glucosidase from bakers yeast. 
Conclusions
A concise approach to the synthesis of isoflavone glycosides has been developed, where the Suzuki-Miyaura coupling between glycosyloxy chromon-3-bromides (i.e., 15 and 21) and aryl boronic acids is employed as the final step. Although there remains room for increasing the coupling yields, and the glycosylation yields as well, the present method provides a quick and divergent access to this type of common natural products. Totally 26 isoflavone glycosides (9a-d, 22a-n, and 23a-h) have been readily synthesized, which are analogs of the potent α-glucosidase inhibitor A-76202 with minor variations at the sugar moiety, the A, and B rings. Evaluation of the inhibitory activities of these compounds against the α-glucosidases of rat liver microsome has led to a preliminary and clear SAR (structure-activity relationship) conclusion: the stereochemistry of the sugar moiety (the α-D-arabinofuranosyl unit) and the 8-hydroxyl group in the A ring are crucial to the activity, while variations on the B ring of the isoflavone 7-O-glycosides are largely tolerated to retain the potent α-glucosidase inhibitory activities.
Experimental
General methods [12] General procedure for assay of the α-glucosidase inhibitory activity IC 50 value was determined at 37 o C in 0. 5, 159.1, 157.7, 154.6, 153.2, 131.8, 126.2, 124.4, 123.1, 119.3, 116.6, 116.3, 110.0, 90.1, 82.4, 79 .0, 63.5. 157.4, 153.4, 148.1, 146.3, 136.4, 130.4, 123.5, 122.7, 120.0, 115.3, 115.2, 115.16, 115.10, 107.2, 84.9, 74.7, 70.2, 62 150.2, 148.3, 137.6, 131.7, 126.0, 124.4, 121.8, 117.0, 116.5, 115.8, 104.2, 77.5, 74.8, 71.2, 67 MeOH =10 : 1). Hz, 3 H). 4, 170.5, 170.4, 169.9, 169.4, 154.8, 152.0, 149.9, 128.8, 123.6, 120.7, 113.8, 113.0, 104.5, 82.0, 81.1, 76.7, 62.7, 33.7, 31.2, 24.6, 22.2, 20.7, 20.6, 13.9 at 0 o C, and the solution was stirred in an ice-bath for 45 min before the addition of 13 (5.8 g, 10.85 mmol) in CH 2 Cl 2 (25 mL). The ice-bath was removed and the reaction mixture was allowed to warm up to rt and stayed 2 h. Pyridine (5.7 mL, 66.47 mmol) was then added, and the stirring was continued for an additional 1 h. 170.4, 170.38, 169.9, 169.4, 153.2, 152.3, 149.6, 128.6, 124.2, 118.8, 114.5, 110.9, 104.5, 82.2, 81.1, 76.7, 62.7, 33.7, 31.2, 24.6, 22.2, 20.7, 20.62, 20.60, 13.9 ; 
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1-(2,4,6-Trihydroxyphenyl)ethanone (16):
A solution of phloroglucinol (25.0 g, 198 mmol) and Ac 2 O (190 mL, 199.5 mmol) in BF 3 ·OEt 2 (75 mL) was stirred at rt for 34 h, before it was poured into 10% NaOAc (700 mL) and stirred overnight. The precipitate was filtered off, washed with water and dried to give the crude 16 (24 g) as a yellow
solid. R f 0.74 (CH 2 Cl 2 : MeOH =5 : 1). 7, 172.3, 170.5, 170.1, 169.5, 159.5, 158.7, 153.9, 150.8, 113.9, 113.5, 109.9, 103.8, 102.1, 82.2, 81.1, 76.7, 62.8, 34.2, 31.3, 24.1, 22.4, 20.73, 20.68, 20.65, 13.9 ; 3, 170.5, 170.1, 169.9, 169.5, 159.8, 158.3, 152.5, 150.9, 111.6, 110.6, 103.9, 102.0, 82.3, 81.1, 76.6, 62.8, 57.9, 34.1, 31.3, 24.1, 22.4, 20.75, 20.70, 20.66, 13.9 2, 165.0, 163.0, 159.3, 157.3, 108.9, 108.2, 107.2, 102.0, 96.5, 87.4, 83.9, 78.5, 63 .0; ESI-MS (m/z): 410.8 (M + Na + ).
5,7-Dihydroxy
Suzuki-Miyaura coupling
General procedure A: Pd(OAc) 2 given in the General procedure A provided the coupling products. The yields are given in Table 2 . 5, 155.9, 149.7, 148.3, 138.0, 133.6, 130.6, 129.7, 129.4, 126.1, 121.4, 116.8, 115.8, 109.1, 88.7, 83.0, 78.9, 63 4',8-Dihydroxyisoflavon-7-yl α-D-arabinofuranoside (22h, A-76202) [10] 3',8-Dihydroxyisoflavon-7-yl α-D-arabinofuranoside ( 6, 158.8, 155.7, 150.0, 148.7, 138.9, 134.9, 130.7, 126.2, 121.7, 117.7, 116.5, 116.4, 116.2, 109.4, 88.9, 83 3, 150.6, 144.4, 131.1, 125.6, 122.1, 116.7, 124.0, 112.1, 109.1, 88.3, 83 
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